Department of Biological Regulation, Weizmann Institute of Science, Rehovot, Israel.
National Institute for Biotechnology in the Negev and Department of Microbiology, Immunology and Genetics, Ben-Gurion University of the Negev, Beer-Sheva, Israel.
Nat Commun. 2019 Nov 8;10(1):5092. doi: 10.1038/s41467-019-13075-8.
Chromodomain helicase DNA binding protein 2 (Chd2) is a chromatin remodeller implicated in neurological disease. Here we show that Chaserr, a highly conserved long noncoding RNA transcribed from a region near the transcription start site of Chd2 and on the same strand, acts in concert with the CHD2 protein to maintain proper Chd2 expression levels. Loss of Chaserr in mice leads to early postnatal lethality in homozygous mice, and severe growth retardation in heterozygotes. Mechanistically, loss of Chaserr leads to substantially increased Chd2 mRNA and protein levels, which in turn lead to transcriptional interference by inhibiting promoters found downstream of highly expressed genes. We further show that Chaserr production represses Chd2 expression solely in cis, and that the phenotypic consequences of Chaserr loss are rescued when Chd2 is perturbed as well. Targeting Chaserr is thus a potential strategy for increasing CHD2 levels in haploinsufficient individuals.
染色质解旋酶 DNA 结合蛋白 2(Chd2)是一种染色质重塑因子,与神经疾病有关。本文作者发现,Chaserr 是一种高度保守的长链非编码 RNA,由 Chd2 转录起始位点附近的区域转录而来,与 Chd2 位于同一链上,它与 CHD2 蛋白协同作用,维持 Chd2 的正常表达水平。Chaserr 在小鼠中缺失会导致纯合子小鼠出生后早期死亡,杂合子小鼠严重生长迟缓。从机制上讲,Chaserr 的缺失会导致 Chd2 mRNA 和蛋白水平显著升高,进而通过抑制高表达基因下游的启动子,导致转录干扰。作者进一步表明,Chaserr 的产生仅在顺式抑制 Chd2 的表达,并且当 Chd2 受到干扰时,Chaserr 缺失的表型后果也得到挽救。因此,靶向 Chaserr 可能是增加杂合不足个体中 CHD2 水平的一种潜在策略。